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F), there was no difference in the frequency of CD4 + IFN- + T cells in dLNs and spleen of 249 & E show that IL-17 cooperates with suboptimal dose of IFN- to mediate increased NO 250 production and more effective parasite killing (compared to treatment with IFN- or IL-17 251 alone). Similarly, we observed increased iNOS2 mRNA expression at the site of infection 252 in PTX3 -/mice compared to WT counterparts ( Fig 6F) , which confirmed our in vitro 253 findings. Collectively, our results show that the enhanced resistance of PTX3 -/mice to L. 254 major is due to enhanced IL-17A production, which synergizes with IFN- to enhance NO 255 production, leading to more effective killing of parasites in infected macrophages.
257
Discussion:
259
Herein we showed that PTX3 levels were elevated in skin lesions from patients and mice 260 suffering from CL, suggesting that this innate pattern recognition molecule may play a 261 critical role in disease pathogenesis. Using a loss of function approach, we showed that 262 deficiency of PTX3 resulted in enhanced resistance to L. major, and this was associated 263 with increased IL-17 (but not IFN- response. Neutralization studies showed that the 264 enhanced resistance of PTX3 -/mice to L. major is due to enhanced Th17 responses in 265 these mice. In contrast, administration of rPTX3 led to increased susceptibility to L.
266
major which was associated with a dramatic downregulation of Th17 responses and IL-
267
17A production by lymph node cells draining the infection site. Using an in vitro 268 approach, we showed that CD4 + T cells from PTX3 -/mice showed enhanced expression 269 of Th17 transcription factors that drive Th17 differentiation. Collectively, these results
270
show, for the first time, that PTX3 is a negative regulator of Th17 response during 271 Leishmania major infection.
272
The expression of PTX3, a key molecule of the innate immune defense system, 273 is upregulated in response to different stimuli such as inflammatory cytokines (IL-1β,
274
TNFα), TLR agonists (e.g. LPS); distinct microbial associated molecular patterns (such 275 as OmpA, lipoarabinomannans) and some pathogens (E. coli, S. aureus) (19, 44-46).
276
Studies with PTX3 -/and PTX3-overexpressing mice have shown that PTX3 mediates 
